Prescriber's Corner
Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
Nancy M. Nix, PharmD, BCPS, BCOP, Olivia Burdine, PharmD, and Makeda Walker, PharmD
From St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, Hilton Head, South Carolina; University of Georgia, Athens, Georgia; Mercer University, Atlanta, Georgia
Authors' disclosures of potential conflicts of interest are found at the end of this article.
Nancy M. Nix, PharmD, BCPS, BCOP, St. Joseph’s/Candler Health System–South Carolina Cancer Specialists, PO Box 21824, Hilton Head, SC 29925. E-mail: nixna@sjchs.org
J Adv Pract Oncol 2014;5:294–296 |
DOI: 10.6004/jadpro.2014.5.4.7 |
© 2014 Harborside Press®
For access to the full length article, please
sign in.
